Adaptation of a human gut epithelial model in relation to the assessment of clinical pharmacokinetic parameters for selected tyrosine kinase inhibitors
The absorption, efflux and transport properties of two of the most commonly used tyrosine kinase inhibitors (TKIs), Erlotinib (E) and Gefitinib (G) were investigated using an adapted workable methodology of a 3-day Caco-2 cell monolayer transwell system, a standard model to test drug permeability an...
Saved in:
Main Authors: | Richard Honeywell (Author), Christien Fatmawati (Author), Marita Buddha (Author), Sarina Hitzerd (Author), Ietje Kathman (Author), Godefridus Peters (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2015-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subcellular localization of several structurally different tyrosine kinase inhibitors
by: Richard Honeywell, et al.
Published: (2018) -
Transport of six tyrosine kinase inhibitors: active or passive?
by: Richard J. Honeywell, et al.
Published: (2016) -
ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors
by: Godefridus J. Peters, et al.
Published: (2016) -
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
by: Shan Jing, et al.
Published: (2023) -
Tyrosine kinases in rheumatoid arthritis
by: Kobayashi Akiko, et al.
Published: (2011)